Precision radiation plus immunotherapy: a new hope for mesothelioma patients?
NCT ID NCT04926948
First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 30 times
Summary
This early-phase trial is testing whether combining a precise type of radiation (SBRT) with immunotherapy can help treat pleural mesothelioma, a rare cancer of the lung lining. The study involves 20 adults with confirmed mesothelioma and aims to see if the combination is safe and feasible. The goal is to improve how the tumor responds to treatment while reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLEURAL MESOTHELIAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.